ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

OPTN OptiNose Inc

1.4315
-0.0485 (-3.28%)
After Hours
Last Updated: 17:21:54
Delayed by 15 minutes

Period:

Draw Mode:

Volume 399,834
Bid Price 1.44
Ask Price 1.47
News -
Day High 1.50

Low
0.90

52 Week Range

High
2.10

Day Low 1.41
Company Name Stock Ticker Symbol Market Type
OptiNose Inc OPTN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0485 -3.28% 1.4315 17:21:54
Open Price Low Price High Price Close Price Prev Close
1.49 1.41 1.50 1.46 1.48
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
1,734 399,834 $ 1.46 $ 584,254 - 0.90 - 2.10
Last Trade Time Type Quantity Stock Price Currency
17:15:14 formt 260 $ 1.4315 USD

OptiNose Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
165.6M 112.65M - 70.99M -35.48M -0.32 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

OptiNose News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No OPTN Message Board. Create One! See More Posts on OPTN Message Board See More Message Board Posts

Historical OPTN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.721.721.411.55608,891-0.2885-16.77%
1 Month1.842.101.411.80985,903-0.4085-22.20%
3 Months1.212.101.161.65559,8440.221518.31%
6 Months1.242.100.95531.48429,5380.191515.44%
1 Year1.832.100.901.38448,489-0.3985-21.78%
3 Years3.524.300.902.03337,352-2.09-59.33%
5 Years9.9011.660.903.52341,807-8.47-85.54%

OptiNose Description

OptiNose Inc is a US-based specialty pharmaceutical company that focuses on the development and commercialization of products for patients treated by ear, nose, and throat, and allergy specialists. The lead product of the company, XHANCE nasal spray, utilizes a proprietary breath powered exhalation delivery system, to deliver a topically acting and potent anti-inflammatory corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps. The XHANCE is able to deliver medication to the primary site of inflammation high and deep in the nasal passages in regions not adequately reached by intranasal steroids. The pipeline products of the company include XHANCE, OPN-300, OPN-021, and AVP-825.

Your Recent History

Delayed Upgrade Clock